853
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Interaction of Depressive and Anxiety Symptoms on the Mortality of Patients with COPD: A Preliminary Study

, , , , , , , , & show all

References

  • Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Jan21.pdf
  • Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. CHEST 2011; 139(1):165–173.
  • Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5(5):647–662.
  • Mikkelsen RL, Middelboe T'P, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psych 2004; 58(1): 65–70.
  • Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 2006; 35(5): 457–459.
  • Cuijpers P, Schoevers RA. Increased mortality in depressive disorders: a review. Curr Psych Rep 2004; 6(6):430–437.
  • Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML. The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med 2007; 146(10):689–698.
  • Mykletun A, Bjerkeset O, Øverland S, Prince M, Dewey M, Stewart R. Levels of anxiety and depression as predictors of mortality: the HUNT study. BJP 2009, 195:118–125.
  • de Voogd JN, Wempe JB, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R. More Evidence that Depressive Symptoms Predict Mortality in COPD Patients: Is Type D Personality an Alternative Explanation? Ann Behav Med 2009; 38(2):86–93.
  • Cole MG. Does depression in older medical inpatients predict mortality? A systematic review. Gen Hosp Psych 2007; 29(5):425–430.
  • Saz P, Dewey ME. Depression, depressive symptoms and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psych 2001; 16(6):622–630.
  • Lou P, Zhu Y, Chen Pp, Zhang P, Yu J, Zhang N, Chen N, Zhang L, Wu H, Zhao J. Vulnerability, beliefs, treatments and economic burden of chronic obstructive pulmonary disease in rural areas in China: a cross-sectional study. BMC Public Health 2012; 12:287.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6):361–370.
  • Zheng LL, Wang YL, Li HL. Application of hospital anxiety and depression scale in general hospital: an analysis in reliability and validity. Shanghai Archiv Psychiatr 2003; 15: 264–266.
  • Yumin Zh, Guoping H, Dali W, Shaoyi W, Yujun W, Zhigang L, Jinxin H, Zhe Sh, Gongyong P, Shengming L, Jiachun L, Jingping Zh, Jian W, Nanshan Zh, Pixin R. Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial. BMJ 2010; 341:c6387.
  • American Thoracic Society. Standardization of spirometry 1994—update. Am J Respir Crit Care Med 1995; 152:1107–1136.
  • Bestall JC, Paul EA, Garrod R, Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581–586.
  • American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
  • Rothman KJ, Greenland S, Lash T L. Modern epidemiology, 3rd edition (M). Philadelphia: Lippincott Williams & Wilkins, 2008.
  • Hosmer DW, Lemeshow S. Confidence interval estimation of interaction (J). Epidemiology 1992; 3(5):452–456.
  • Knol MJ, VanderWeele TJ, Groenwold RHH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26(6):433–438.
  • Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis 2012; 7:571–576.
  • Bentsen SB, Henriksen AH, Wentzel-Larsen T, Hanestad BR, Wahl AK. What determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjective health status of COPD patients. Health Qual Life Outcom 2008; 6:115.
  • Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985; 87(1):35–38.
  • Ryu YJ, Chun E-M, Lee JH, Chang JH. Prevalence of depression and anxiety in outpatients with chronic airway lung disease. Kor J Intern Med 2010; 25(1):51–57.
  • Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47(4):312–319.
  • Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006; 100(1):87–93.
  • Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9(11):2346–2350.
  • Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O'Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161(15):1849–1856.
  • Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003; 26(10):2822–2828.
  • DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160(14):2101–2107.
  • Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34(5):491–496.
  • Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT, Benditt JO, Mosenifar Z, McKenna R Jr, Curtis JL, Fishman AP, Martinez FJ. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167(21):2345–2353.
  • Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med, 2012; 185(9):918–923.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.